NCT06344338
- Conditions
- Nervous System Diseases, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, +4 more
- Locations
-
- Xuanwu Hospital, Capital Medical University Beijing, Beijing Municipality, China
Clinical trial condition
Refractory Status Epilepticus
Explore clinical trials studying Refractory Status Epilepticus. Study availability and eligibility vary by location and protocol.
6 public trials
2 recruiting studies
Refractory Status Epilepticus trial results
NCT05851391
- Conditions
- Anoxia-Ischemia, Cerebral, Anoxic-Ischemic Encephalopathy, Brain Diseases, +18 more
- Locations
-
- Zuckerberg San Francisco General Hospital San Francisco, California, United States
Not yet recruiting
Ketamine for the Treatment of Refractory Status Epilepticus
NCT07177235
- Conditions
- Nervous System Diseases, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, +4 more
- Locations
-
- Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States
Completed
Multicenter Retrospective Study of Isoflurane in Refractory and Super-Refractory Status Epilepticus
NCT05830864
- Conditions
- Nervous System Diseases, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, +4 more
- Locations
-
- Ch Bethune Beuvry Beuvry, France
- CHU Brest Brest, France
- GH Sud Ile de France, Hôpital de Melun-Sénart Melun, France
- CH Toulon - Sainte Musse Toulon, France
NCT04333082
- Conditions
- Nervous System Diseases, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, +4 more
- Locations
-
- Clinic for Intensive Care Medicine, University Hospital Basel Basel, Switzerland
NCT01796574
- Conditions
- Brain Diseases, Central Nervous System Diseases, Epilepsy, +9 more
- Locations
-
- Mayo Clinic Phoenix, Arizona, United States
- Queen's Medical Center Honolulu, Hawaii, United States
- Rush University Medical Center Chicago, Illinois, United States
- Johns Hopkins University Baltimore, Maryland, United States